Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.

M.D. Wissing; J. Mendonca; E. Kim; E Kim; J.S. Shim; N.S. Kaelber; H. Kant; H. Hammers; T. Commes; P.J. van Diest; J.O. Liu; S.K. Kachhap

Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.

Translated title of the contribution: Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.

M.D. Wissing
, J. Mendonca
, E. Kim
, E Kim
, J.S. Shim
, N.S. Kaelber
, H. Kant
, H. Hammers
, T. Commes
, P.J. van Diest
, J.O. Liu
, S.K. Kachhap

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.
Original language	Undefined/Unknown
Pages (from-to)	401-410
Number of pages	10
Journal	Cancer Biology & Therapy
Volume	14
Issue number	5
Publication status	Published - 2013

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/23377825

Cite this

Wissing, M. D., Mendonca, J., Kim, E., Kim, E., Shim, J. S., Kaelber, N. S., Kant, H., Hammers, H., Commes, T., van Diest, P. J., Liu, J. O., & Kachhap, S. K. (2013). Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells. Cancer Biology & Therapy, 14(5), 401-410. http://www.ncbi.nlm.nih.gov/pubmed/23377825

@article{09db17f754324f98a7857a14d6959ef6,

title = "Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.",

author = "M.D. Wissing and J. Mendonca and E. Kim and E Kim and J.S. Shim and N.S. Kaelber and H. Kant and H. Hammers and T. Commes and \{van Diest\}, P.J. and J.O. Liu and S.K. Kachhap",

year = "2013",

language = "Undefined/Unknown",

volume = "14",

pages = "401--410",

journal = "Cancer Biology \& Therapy",

issn = "1538-4047",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

Wissing, MD, Mendonca, J, Kim, E, Kim, E, Shim, JS, Kaelber, NS, Kant, H, Hammers, H, Commes, T, van Diest, PJ, Liu, JO & Kachhap, SK 2013, 'Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.', Cancer Biology & Therapy, vol. 14, no. 5, pp. 401-410. <http://www.ncbi.nlm.nih.gov/pubmed/23377825>

TY - JOUR

T1 - Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.

AU - Wissing, M.D.

AU - Mendonca, J.

AU - Kim, E.

AU - Kim, E

AU - Shim, J.S.

AU - Kaelber, N.S.

AU - Kant, H.

AU - Hammers, H.

AU - Commes, T.

AU - van Diest, P.J.

AU - Liu, J.O.

AU - Kachhap, S.K.

PY - 2013

Y1 - 2013

M3 - Article

SN - 1538-4047

VL - 14

SP - 401

EP - 410

JO - Cancer Biology & Therapy

JF - Cancer Biology & Therapy

IS - 5

ER -